Jpmorgan Chase & CO Tyra Biosciences, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 85,490 shares of TYRA stock, worth $906,194. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85,490
Previous 91,115 6.17%
Holding current value
$906,194
Previous $1.27 Million 37.2%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$9.3 - $16.73 $52,312 - $94,106
-5,625 Reduced 6.17%
85,490 $795,000
Q4 2024

Feb 12, 2025
SELL
$13.9 - $28.61 $3.86 Million - $7.94 Million
-277,532 Reduced 75.28%
91,115 $1.27 Million
Q3 2024

Dec 26, 2024
BUY
$16.7 - $24.36 $65,063 - $94,906
3,896 Added 1.07%
368,647 $8.67 Million
Q3 2024

Nov 08, 2024
BUY
$16.7 - $24.36 $65,063 - $94,906
3,896 Added 1.07%
368,647 $8.67 Million
Q2 2024

Dec 26, 2024
SELL
$14.45 - $20.22 $56,297 - $78,777
-3,896 Reduced 1.06%
364,751 $5.83 Million
Q2 2024

Aug 12, 2024
SELL
$14.45 - $20.22 $228,974 - $320,406
-15,846 Reduced 4.16%
364,751 $5.83 Million
Q1 2024

Dec 26, 2024
BUY
$11.61 - $20.0 $138,739 - $239,000
11,950 Added 3.24%
380,597 $6.24 Million
Q1 2024

May 10, 2024
SELL
$11.61 - $20.0 $245,075 - $422,180
-21,109 Reduced 5.25%
380,597 $6.24 Million
Q4 2023

Dec 26, 2024
BUY
$11.01 - $14.95 $363,979 - $494,232
33,059 Added 8.97%
401,706 $5.56 Million
Q4 2023

Feb 12, 2024
BUY
$11.01 - $14.95 $45,008 - $61,115
4,088 Added 1.03%
401,706 $5.56 Million
Q3 2023

Nov 14, 2023
SELL
$13.15 - $16.08 $339,309 - $414,912
-25,803 Reduced 6.09%
397,618 $5.48 Million
Q2 2023

Aug 11, 2023
BUY
$11.99 - $17.51 $2.77 Million - $4.04 Million
230,912 Added 119.95%
423,421 $7.21 Million
Q1 2023

May 18, 2023
BUY
$6.85 - $16.22 $69,589 - $164,778
10,159 Added 5.57%
192,509 $3.09 Million
Q1 2023

May 11, 2023
SELL
$6.85 - $16.22 $115,470 - $273,420
-16,857 Reduced 8.46%
182,350 $2.93 Million
Q4 2022

Feb 13, 2023
SELL
$5.68 - $8.81 $115,531 - $179,195
-20,340 Reduced 9.26%
199,207 $1.51 Million
Q3 2022

Nov 14, 2022
SELL
$6.61 - $12.42 $32,686 - $61,416
-4,945 Reduced 2.2%
219,547 $1.93 Million
Q2 2022

Aug 11, 2022
SELL
$5.26 - $11.19 $20,987 - $44,648
-3,990 Reduced 1.75%
224,492 $1.61 Million
Q1 2022

May 11, 2022
BUY
$10.03 - $14.09 $741,247 - $1.04 Million
73,903 Added 47.81%
228,482 $2.45 Million
Q4 2021

Feb 10, 2022
BUY
$12.23 - $31.35 $1.89 Million - $4.85 Million
154,579 New
154,579 $2.18 Million

Others Institutions Holding TYRA

# of Institutions
120
Shares Held
59.8M
Call Options Held
0
Put Options Held
0
View Full List

About Tyra Biosciences, Inc.

TYRA Quotes by TradingView
  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $445M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email